Genomma Lab Internacional (GNMLF) Projected to Post Quarterly Earnings on Wednesday

Genomma Lab Internacional (OTCMKTS:GNMLF) will likely be issuing its results after the market closes on Wednesday, April 22nd. Analysts expect the company to announce earnings of $0.0248 per share and revenue of $12.4990 million for the quarter.

Genomma Lab Internacional Stock Performance

Shares of GNMLF opened at $1.08 on Monday. The business has a 50-day simple moving average of $1.00 and a two-hundred day simple moving average of $1.01. Genomma Lab Internacional has a 52 week low of $0.91 and a 52 week high of $1.27.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.